Can a smartphone app improve quality of life for blood cancer patients?
NCT ID NCT06472128
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a digital app called DREAMLAND designed to improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) undergoing intensive chemotherapy. About 200 hospitalized patients will either use DREAMLAND or a standard wellness app. Researchers will compare how patients rate their quality of life at day 20 and beyond.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital application (DREAMLAND)
What this could lead to
If it works, this could provide a simple, self-guided digital tool to help AML patients feel better emotionally and physically during treatment.
What could go wrong
This is an early-stage behavioral study with 200 participants, so results may not apply to all patients. The app is only available in English, limiting who can use it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Duke University
NOT_YET_RECRUITINGDurham, North Carolina, 27710, United States
Contact Email: •••••@•••••
-
Fred Hutchinson Cancer Research Center (FHCRC)
NOT_YET_RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
-
Massachusetts General Hospital (MGH)
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••